1 withdrawn. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
Follow IntegoGen, LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Allogeneic Micronized Amniotic Membrane Product for the Treatment of Hidradenitis Suppurativa AMP-001 Low Dose, AMP-001 Medium Dose, AMP-001 High Dose - Hidradenitis Suppurativa | Phase 1 | Withdrawn | IntegoGen, LLC | 2021-04-01 | 2021-09-08 |
United States (1)